The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive

Vasc Health Risk Manag. 2011:7:771-6. doi: 10.2147/VHRM.S25724. Epub 2011 Dec 19.

Abstract

Aim: Chronic heart failure is associated with endothelial dysfunction and insulin resistance. The aim of this investigation was to study insulin-stimulated endothelial function and glucose uptake in skeletal muscles in patients with heart failure in comparison to patients with type 2 diabetes.

Methods: Twenty-three patients with systolic heart failure and no history of diabetes, seven patients with both systolic heart failure and type 2 diabetes, 19 patients with type 2 diabetes, and ten healthy controls were included in the study. Endothelial function was studied by venous occlusion plethysmography. Insulin-stimulated endothelial function was assessed after intra-arterial infusion of insulin followed by co-infusion with serotonin in three different dosages. Forearm glucose uptake was measured during the insulin infusion.

Results: Patients with systolic heart failure had impaired insulin-stimulated endothelial function. The percentage increase in blood flow during co-infusion with insulin and serotonin dose response study was 24.74% ± 6.16%, 23.50% ± 8.32%, and 22.29% ± 10.77% at the three doses respectively, compared to the healthy control group 45.96% ± 11.56%, 67.40% ± 18.11% and 84.57% ± 25.73% (P = 0.01). Insulin-stimulated endothelial function was similar in heart failure patients and patients with type 2 diabetes, while it was further deteriorated in patients suffering from both heart failure and diabetes with a percentage increase in blood flow of 19.15% ± 7.81%, -2.35% ± 11.76%, and 5.82% ± 17.70% at the three doses of serotonin, respectively. Forearm glucose uptake was impaired in patients with heart failure compared to healthy controls (P = 0.03) and tended to be further impaired by co-existence of diabetes (P = 0.08).

Conclusion: Systolic heart failure and type 2 diabetes result in similar vascular insulin resistance and reduced muscular insulin-stimulated glucose uptake. The effects of systolic heart failure and type 2 diabetes appear to be additive.

Keywords: diabetes; endothelial function; heart failure; insulin resistance.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiopathology
  • Female
  • Forearm / blood supply
  • Glucose / metabolism
  • Heart Failure / physiopathology*
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Infusions, Intra-Arterial
  • Insulin / administration & dosage*
  • Insulin Resistance / physiology
  • Male
  • Middle Aged
  • Muscle, Skeletal / metabolism
  • Plethysmography
  • Regional Blood Flow / drug effects
  • Serotonin / administration & dosage
  • Serotonin Receptor Agonists / administration & dosage
  • Vasodilation / drug effects

Substances

  • Hypoglycemic Agents
  • Insulin
  • Serotonin Receptor Agonists
  • Serotonin
  • Glucose